Business Context and Reporting Period
Company: The Ensign Group, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2010
Business Overview: The Company operates 81 skilled nursing and assisted living facilities, plus one home health and hospice operation, across seven states (California, Arizona, Texas, Washington, Utah, Colorado, and Idaho). As of the reporting date, the Company owned 51 facilities and leased 30, with a total capacity of approximately 9,343 operational beds. The Company is a holding company with no direct operating assets; all operations are conducted through separate, wholly-owned subsidiaries.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2010 | Nine Months Ended Sep 30, 2010 |
|---|---|---|
| Revenue | $164.7 million | $476.8 million |
| Net Income | $9.9 million | $28.9 million |
| Diluted EPS | $0.47 | $1.37 |
| Operating Income | $18.6 million | $54.4 million |
| Operating Margin | 11.3% | 11.4% |
| Net Cash from Operating Activities | N/A | $34.5 million |
| Cash and Cash Equivalents (End of Period) | $36.9 million | $36.9 million |
| Total Debt (Long-term + Current) | $108.0 million | $108.0 million |
| EBITDA | $22.8 million | $66.6 million |
| EBITDAR | $26.5 million | $77.4 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 23.9% ($31.7 million) for the three months and 20.6% ($81.4 million) for the nine months ended September 30, 2010, compared to the prior year periods. This growth was primarily driven by acquisitions (19 facilities and one home health operation acquired since Jan 1, 2009) and improved occupancy and skilled mix at same facilities.
- Profitability: Net income increased 28.6% for the quarter and 21.3% for the nine-month period. Operating margins improved slightly to 11.3% (quarter) and 11.4% (nine months) due to cost management and revenue mix improvements.
- Acquisitions: During the nine months ended September 30, 2010, the Company acquired four skilled nursing facilities and one home health/hospice operation for approximately $18.8 million in cash, adding 435 operational beds.
- Cost of Services: Cost of services increased 22.6% for the quarter and 20.1% for the nine months, largely due to the inclusion of newly acquired facilities and increased wages/benefits. However, as a percentage of revenue, costs decreased slightly.
- Interest Expense: Interest expense increased significantly (90.5% for the quarter) due to an additional $40 million added to the Term Loan in November 2009.
Guidance, Outlook, Risks, and Unusual Items
- Regulatory Investigation: The Company is subject to an ongoing investigation by the U.S. Department of Justice (DOJ) and the U.S. Attorney's office regarding billing and reimbursement processes at certain facilities. Search warrants were served in December 2008. The Company has not been formally charged but notes that the outcome could materially affect financial condition. A special committee of independent directors was appointed in September 2010 to oversee the response.
- Revenue Adjustment: In the quarter ended June 30, 2010, the Company accrued a revenue adjustment of approximately $0.5 million (plus interest) related to estimated Medicare overpayments identified during internal billing reviews, resulting in a net income impact of approximately $0.3 million.
- Healthcare Reform: The Patient Protection and Affordable Care Act (PPACA) introduces new transparency requirements, potential payment suspensions during fraud investigations, and expanded False Claims Act liability. The Company anticipates these changes could impact reimbursement rates and operational costs.
- Occupancy and Mix: Consolidated occupancy remained flat at 79.6% for the nine months ended September 30, 2010, compared to the prior year, due to the lower initial occupancy of recently acquired facilities. However, "Same Facility" occupancy increased to 82.9%.
- Liquidity: The Company maintains a $50 million revolving credit facility (Revolver) with GE Capital, with no outstanding borrowings as of September 30, 2010. Management believes cash flow from operations and the Revolver are sufficient for the next 12 months.
Investor Verification Checklist
- DOJ Investigation Status: Monitor for any formal charges, settlements, or findings related to the ongoing DOJ investigation into billing practices.
- Medicare/Medicaid Reimbursement Rates: Verify the impact of state budget constraints (particularly in California) and federal policy changes on reimbursement rates and payment delays.
- Acquisition Integration: Assess the financial performance and occupancy trends of the 19 facilities acquired since 2009 to ensure they meet projected return on invested capital targets.
- Debt Covenants: Confirm continued compliance with financial covenants (occupancy, debt service coverage, project yield) under the Amended Term Loan and Revolver agreements.
- Self-Insurance Reserves: Review the adequacy of reserves for general liability, professional liability, and workers' compensation, given the volatility of actuarial estimates.